Baseline distribution of participants with depression and impaired quality of life in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial

Circulation: Heart Failure

Volumn 8, Issue 2, 2015, Pages 268-277

  Hamo, Carine E ^a   Heitner, John F ^b   Pfeffer, Marc A ^c   Kim, Hae Young ^d   Kenwood, Christopher T ^d   Assmann, Susan F ^d   Solomon, Scott D ^c   Boineau, Robin ^e   Fleg, Jerome L ^e   Spertus, John A ^f   Lewis, Eldrin F ^c  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

depression; heart failure; quality of life

Indexed keywords

ANTIDIABETIC AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; MINERALOCORTICOID ANTAGONIST;

AGED; ANGINA PECTORIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; COMORBIDITY; HEART FAILURE; HEART STROKE VOLUME; LIFESTYLE; PSYCHOLOGY; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSION; FEMALE; HEART FAILURE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROGNOSIS; QUALITY OF LIFE; SPIRONOLACTONE; STROKE VOLUME;

EID: 84937574853     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001838     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220. doi: 10.1161/CIR.0b013e31823ac046.
2. Maeder MT, Kaye DM. Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol. 2009;53:905-918. doi: 10.1016/j.jacc.2008.12.007.
3. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259. doi: 10.1056/NEJMoa052256.
4. West R, Liang L, Fonarow GC, Kociol R, Mills RM, O'Connor CM, Hernandez AF. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. Eur J Heart Fail. 2011;13:945-952. doi: 10.1093/eurjhf/hfr064.
5. Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013;126:393-400. doi: 10.1016/j.amjmed.2012.10.022.
6. Fontes-Carvalho R, Leite-Moreira A. The pathophysiology of heart failure with preserved ejection fraction and its therapeutic implications. Rev Port Cardiol. 2009;28:63-82.
7. Hoekstra T, Lesman-Leegte I, van Veldhuisen DJ, Sanderman R, Jaarsma T. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2011;13:1013-1018. doi: 10.1093/eurjhf/hfr072.
8. Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, Pfeffer MA; CHARM Investigators. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007;9:83-91. doi: 10.1016/j.ejheart.2006.10.012.
9. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23:1867-1876.
10. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Petersen S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing. 1997;26:7-13.
11. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87:235-241.
12. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527-1537. doi: 10.1016/j.jacc.2006.06.055.
13. Gottlieb SS, Kop WJ, Ellis SJ, Binkley P, Howlett J, O'Connor C, Blumenthal JA, Fletcher G, Swank AM, Cooper L; HF-ACTION Investigators. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol. 2009;103:1285-1289. doi: 10.1016/j.amjcard.2009.01.025.
14. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA; Cardiovascular Outcomes Research Consortium. Depressive symptoms are the strongest predictors of shortterm declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811-1817.
15. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, Clasusell N, Diaz R, Fleg JL, Gordeev I, McKinlay S, O'Meara E, Shaburishvili T, Pitt B, Pfeffer MA. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in participants with symptomatic heart failure and preserved ejection fraction. Am Heart J. 2011;162:966-972.
16. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245-1255.
17. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2:169-180.
18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
19. Valencia-Martín JL, Galán I, Guallar-Castillón P, Rodríguez-Artalejo F. Alcohol drinking patterns and health-related quality of life reported in the Spanish adult population. Prev Med. 2013;57:703-707. doi: 10.1016/j.ypmed.2013.09.007.
20. Volk RJ, Cantor SB, Steinbauer JR, Cass AR. Alcohol use disorders, consumption patterns, and health-related quality of life of primary care patients. Alcohol Clin Exp Res. 1997;21:899-905.
21. Gordon R, Heim D, MacAskill S. Rethinking drinking cultures: a review of drinking cultures and a reconstructed dimensional approach. Public Health. 2012;126:3-11. doi: 10.1016/j.puhe.2011.09.014.
22. Philipson H, Ekman I, Forslund HB, Swedberg K, Schaufelberger M. Salt and fluid restriction is effective in patients with chronic heart failure. Eur J Hear Fail. 2013;15:1304-1310.
23. Hummel SL, DeFranco AC, Skorcz S, Montoye CK, Koelling TM. Recommendation of low-salt diet and short-term outcomes in heart failure with preserved systolic function. Am J Med. 2009;122:1029-1036. doi: 10.1016/j.amjmed.2009.04.025.
24. Centers for Disease Control and Prevention. QuickStats: prevalence of current depression among persons aged ?12 years, by age group and sex-United States National Health and Nutrition Examination Survey data, 2007-2010. Morb Mort Week Rep. 2012; 60:1747.
25. Jorm AF. Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span. Psychol Med. 2000;30:11-22.
26. Jorm AF, Windsor TD, Dear KBG, Anstey KJ, Christensesn H, Rodgers B. Age group differences in psychological distress: the role of psychological risk factors that vary with age. Psychol Med. 2005; 9:1253-1263.
27. Heo S, Moser DK, Fiegel B, Hall LA, Christman N. Testing a published model of health-related quality of life in heart failure. J Card Fail. 2005;11:372-379.
28. Riedinger MS, Dracup KA, Brecht ML, Padilla G, Sarna L, Ganz PA. Quality of life in patients with heart failure: do gender differences exist? Heart Lung. 2001;30:105-116.
29. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol. 2003;42:2128-2134.
30. Davidson PM, Daly J, Hancock K, Moser D, Chang E, Cockburn J. Perceptions and experiences of heart disease: a literature review and identification of a research agenda in older women. Eur J Cardiovasc Nurs. 2003;2:255-264.
31. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768-1775. doi: 10.1161/CIRCULATIONAHA.108.190769.
32. Thombs BD, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med. 2008;23:2014-2017. doi: 10.1007/s11606-008-0802-y.
33. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE; Cardiovascular Outcomes Research Consortium. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47:752-756. doi: 10.1016/j.jacc.2005.11.021.
34. Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115:1975-1981. doi: 10.1161/CIRCULATIONAHA.106.670901.
35. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O'Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849-1856.
36. Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction. J Cardiol. 2012;60:23-30. doi: 10.1016/j.jjcc.2012.01.010.
37. Tousoulis D, Antoniades C, Drolias A, Stefanadi E, Marinou K, Vasiliadou C, Tsioufis C, Toutouzas K, Latsios G, Stefanadis C. Selective serotonin reuptake inhibitors modify the effect of beta-blockers on longterm survival of patients with end-stage heart failure and major depression. J Card Fail. 2008;14:456-464. doi: 10.1016/j.cardfail.2008.02.015.
38. Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch Intern Med. 2002;162:1860-1866.
39. de Leon CF, Grady KL, Eaton C, Rucker-Whitaker C, Janssen I, Calvin J, Powell LH. Quality of life in a diverse population of patients with heart failure: baseline findings from tHE Heart Failure Adherence and Retention Trial (HART). J Cardiopulm Rehabil Prev. 2009;29:171-178. doi: 10.1097/HCR.0b013e31819a0266.
40. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA; Cardiovascular Outcomes Research Consortium. Depressive symptoms are the strongest predictors of shortterm declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811-1817.